em. prof. dr. Guy Joos
- ORCID iD
-
0000-0002-3149-9444
Show
Sort by
-
- Journal Article
- A1
- open access
Anti-IL-5 treatment, but not neutrophil interference, attenuates inflammation in a mixed granulocytic asthma mouse model, elicited by air pollution
-
- Journal Article
- A1
- open access
Trajectory of neutrophilic responses in a mouse model of pollutant-aggravated allergic asthma
-
- Journal Article
- A1
- open access
How much should be invested in lung care across the WHO European region? Applying a monetary value to disability‑adjusted life‑years within the International Respiratory Coalition’s Lung Facts
-
- Journal Article
- A1
- open access
RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD
-
NO in de uitgeademde lucht, een overzicht
-
Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry
-
- Journal Article
- A1
- open access
ERS statement : a core outcome set for clinical trials evaluating the management of chronic obstructive pulmonary disease (COPD) exacerbations
-
An unexpected cause of constipation and abdominal distension in COPD
-
Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation
-
MiR-223 is increased in lungs of patients with COPD and modulates cigarette smoke-induced pulmonary inflammation